Mode
Text Size
Log in / Sign up

Cardiology

566 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
OCT guidance showed non-significant MACE reduction in true unprotected left main bifurcation disease compared to angiography
Cardiology RCT
OCT guidance showed non-significant MACE reduction in true unprotected left main bifurcation disease compared to angiography Doctors used special imaging tools to help place stents in heart arteries safely
This randomized controlled trial enrolled 227 patients with true unprotected left main bifurcation lesions. Optical coherence tomography (OC…
A study tested using optical coherence tomography to guide stent placement in complex heart artery cases. While the imaging was mostly succe…
Narrative review on anthracycline cardiorenal toxicity and dexrazoxane protection
Cardiology Sys. Review
Narrative review on anthracycline cardiorenal toxicity and dexrazoxane protection Doctors seek better ways to protect heart and kidney health during cancer drug treatment
This narrative review synthesizes evidence on anthracycline-induced cardiorenal toxicity and dexrazoxane's protective role. The authors note…
Cancer treatments called anthracyclines can harm the heart and kidneys. This review explains why doctors need new strategies to keep patient…
Meta-analysis links influenza vaccination to lower mortality in acute heart failure
Cardiology Meta-analysis
Meta-analysis links influenza vaccination to lower mortality in acute heart failure Flu Shot Linked to Lower Death Risk in Heart Failure Patients
This meta-analysis of 5 observational studies found that influenza vaccination was associated with reduced 1-year and 90-day mortality in pa…
A review of five studies found that flu vaccination was associated with about 11% lower risk of death within one year in patients with acute…
Narrative review explores strategic collaborations to expand interventional cardiology access in sub-Saharan Africa
Cardiology Sys. Review
Narrative review explores strategic collaborations to expand interventional cardiology access in sub-Saharan Africa Strategic partnerships help bring heart care services to people in sub-Saharan Africa
This narrative review examines how strategic collaborations can increase equitable access to interventional cardiology in sub-Saharan Africa…
This review looks at how working together can improve heart care in sub-Saharan Africa. It aims to close the gap for patients with coronary …
Omics approaches offer theoretical basis for new diagnostic markers and targeted therapeutic strategies in mitral valve disease management
Cardiology Sys. Review
Omics approaches offer theoretical basis for new diagnostic markers and targeted therapeutic strategies in mitral valve disease management New Clues Emerge About Common Heart Valve Problems
This narrative review explores how omics approaches, including genomics and proteomics, could revolutionize the understanding of mitral valv…
Hidden biological signals in heart valve tissue may lead to earlier detection and better treatments for mitral valve disease.
FDA Approves Cardiogen-82 (Rubidium Rb 82) for Myocardial Perfusion PET
Cardiology FDA Approval
FDA Approves Cardiogen-82 (Rubidium Rb 82) for Myocardial Perfusion PET FDA approves new heart imaging drug to check blood flow in arteries.
The FDA approved Cardiogen-82, a generator producing Rubidium Chloride Rb 82 Injection, for PET myocardial perfusion imaging in adults with …
The FDA approved Cardiogen-82, a radioactive drug used with PET scans to see blood flow in the heart muscle. It helps doctors evaluate patie…
Review of GLP-1RAs in Type 2 Diabetes and Atherosclerosis Mechanisms
Cardiology Sys. Review
Review of GLP-1RAs in Type 2 Diabetes and Atherosclerosis Mechanisms Diabetes Drugs That May Protect Your Arteries From Clogging
This narrative review synthesizes evidence on glucagon-like peptide-1 receptor agonists (GLP-1RAs) for Type 2 Diabetes and atherosclerosis. …
A class of diabetes drugs originally designed to lower blood sugar may also protect your arteries from the dangerous buildup that leads to h…
Meta-analysis finds lower bleeding risk with apixaban and rivaroxaban vs VKAs in dialysis patients with AF
Cardiology Meta-analysis
Meta-analysis finds lower bleeding risk with apixaban and rivaroxaban vs VKAs in dialysis patients with AF New Blood Thinners Cut Bleeding Risk For Dialysis Patients
This meta-analysis of observational studies and RCTs compared apixaban or rivaroxaban with vitamin K antagonists in dialysis patients with a…
New blood thinners could save lives for dialysis patients by cutting bleeding and stroke risks while waiting for bigger studies to confirm t…
DOACs versus VKAs for left ventricular thrombus management in adults
Cardiology Meta-analysis
DOACs versus VKAs for left ventricular thrombus management in adults Newer Blood Thinners May Be Safer for Heart Clot Patients
A meta-analysis suggests DOACs may be a reasonable alternative to VKAs for left ventricular thrombus, with similar efficacy and potentially …
If you have a blood clot in your heart, newer blood thinners may be just as effective as warfarin with a lower risk of dangerous bleeding.
Case report review of clindamycin use in a 62-year-old male with Neurofibromatosis type 1 and hematoma
Cardiology Sys. Review
Case report review of clindamycin use in a 62-year-old male with Neurofibromatosis type 1 and hematoma A Rare Bleeding Complication Every NF1 Patient Should Know About
This case report review describes the management of a 62-year-old male with Neurofibromatosis type 1 who presented with a hematoma. The pati…
A sudden pain or unexplained lump in someone with NF1 could signal a life-threatening bleed that needs emergency care right away.
FDA approves ticagrelor for multiple indications in cardiology and neurology
Cardiology FDA Approval
FDA approves ticagrelor for multiple indications in cardiology and neurology Brilinta Now Approved for Stroke Prevention in Three Key Groups
The FDA approved ticagrelor (Brilinta) for patients with ACS, CAD at high risk, and acute ischemic stroke or high-risk TIA. In ACS, it was s…
A widely used heart medication now has FDA approval to prevent first strokes in people with diabetes and to protect against repeat strokes a…
UK Biobank guideline review links higher UMOD levels to lower aortic regurgitation progression risk
Cardiology Guideline
UK Biobank guideline review links higher UMOD levels to lower aortic regurgitation progression risk Higher UMOD levels linked to lower risk of needing aortic valve replacement surgery in patients with aortic regurgitation
This observational cohort study from the UK Biobank evaluates circulating UMOD levels as a biomarker for aortic regurgitation progression. A…
New data shows people with higher UMOD levels face a lower chance of needing aortic valve surgery. This finding helps doctors better underst…